Serum FAM19A5 in neuromyelitis optica spectrum disorders: Can it be a new biomarker representing clinical status?

Background: Neuromyelitis optica spectrum disorder (NMOSD) targets astrocytes and elevates the levels of astrocyte-injury markers during attacks. FAM19A5, involved in reactive gliosis, is secreted by reactive astrocytes following central nervous system (CNS) damage. Objective: To investigate the sig...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis 2020-11, Vol.26 (13), p.1700-1707
Hauptverfasser:	Lee, Hye Lim, Seok, Hung Youl, Ryu, Han-Wook, Cho, Eun Bee, Kim, Bong Chul, Kim, Byoung Joon, Min, Ju-Hong, Seok, Jin Myoung, Shin, Ha Young, Kang, Sa-Yoon, Kwon, Oh-Hyun, Lee, Sang-Soo, Oh, Jeeyoung, Sohn, Eun-Hee, Huh, So-Young, Cho, Joong-Yang, Seong, Jae Young, Kim, Byung-Jo
Format:	Artikel
Sprache:	eng
Schlagworte:	Aquaporin 4 Astrocytes Biomarkers Central nervous system Demyelinating diseases Demyelination Gliosis Neuromyelitis Patients Remission
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!